Frequently Asked Questions

MENTORSHIP
What is meant by mentored career development?
This refers to the ways in which the applicant and their mentor plan to support each other. The mentor should be involved in overseeing the means for adequate funding to support necessary research, ensuring protected time for the applicant to complete their research and to investigate career development, and helping the applicant obtain a firm commitment from their institution. Documentation of adequate mentorship is an important component of the grant application and should be carefully addressed.

Does the mentor need to be based at the same institution as the applicant, or can the mentor be based at another institution?

Having a mentor based at a different institution as the applicant is not strictly prohibited. Note however that mentorship, career development, and academic/departmental support are important factors in considering merit for this award, and the mentor/applicant relationship is an important component of the grant application.

NOTIFCATION OF AWARDEES
Awardees will be notified by the American Thoracic Society. All decisions are final.

DISBURSEMENT OF FUNDING TO GRANT RECIPIENTS
How is the grant recipient funding disbursed?
Upon execution of a contract between the recipient’s institution and the American Thoracic Society, funding will be disbursed in three installments:

  • One-third (1/3) upon complete submission of paperwork (IRB, W-9 Form from the institution, sample informed consent documents, if necessary, and IACUC, if necessary) and receipt of an invoice;
  • One-third (1/3) upon satisfactory acceptance of an interim report and receipt of an invoice;
  • One-third (1/3) after completion of the research and upon satisfactory acceptance of the final report and
    approval by at least two Steering Committee members and receipt of a final invoice.

PROGRESS AND FINAL REPORTS
When must I submit progress reports and final reports?
Required reports during the funding period include a 90-day report, an interim progress report at six months, and a final report, due 90 days after the conclusion of the research project. Financial reconciliation and all publications will be required. Templates for the 2022 program will be provided upon contracting of the award.

EXTENSIONS
Will the ATS grant extensions?
Extensions will be considered on an individual basis only and are subject to final approval of the American Thoracic Society. Written requests for extensions must be submitted to the American Thoracic Society for consideration at jguzman@thoracic.org.

PROGRAM FUNDING
Where does the Program get its funding?
The Early Career Investigator Award in Pulmonary Vascular Disease Early Career Investigator Award in Pulmonary Vascular Disease is an independent program of the American Thoracic Society, sponsored by Janssen Pharmaceutical Companies of Johnson & Johnson and managed by Medtelligence. The program was formerly known as ENTELLIGENCE.

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Twitter Facebook LinkedIn Instagram YouTube Social Media Page

AMERICAN THORACIC SOCIETY
25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org

© 1998 - American Thoracic Society, all rights reserved.